Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2026-04-08 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
非经营性资金占用及其他关联资金往来情况专项说明
Audit Report / Information Classification · 95% confidence The document is a specialized audit-related report issued by an accounting firm (容诚会计师事务所) concerning non-operating fund occupation and other related party fund transactions for the fiscal year 2025 of 阳普医疗科技股份有限公司. It references the audited financial statements for the year ending December 31, 2025, and includes a detailed summary table of related party transactions. The document explicitly states it is a "专项说明" (special explanation) related to the audited financial statements and is intended for disclosure purposes in the annual report. It is not the full annual report itself, nor is it a general audit report or certification letter. Given the nature of the document as a standalone audit-related explanatory report focusing on specific financial aspects (non-operating fund occupation and related party transactions), it fits best under the category of Audit Report / Information (AR). The document length is 3415 characters, which is relatively short but contains substantive audit-related content and detailed financial data tables, so it is not merely an announcement or certification. Therefore, the classification is AR with high confidence. FY 2025
2026-04-08 Chinese
关于全资子公司收到医疗器械变更注册（备案）文件的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (665 characters) from a company about its wholly owned subsidiary receiving medical device registration change documents from a regulatory authority. It includes a summary of the changes and a risk notice to investors. There is no financial data, no detailed report, no meeting materials, no voting results, no management discussion, no earnings data, and no mention of any report being attached or published. This is a regulatory announcement about a compliance or registration update. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2026-03-30 Chinese
关于累计诉讼、仲裁案件情况的公告
Legal Proceedings Report Classification · 95% confidence The document is an announcement from a company regarding the cumulative litigation and arbitration cases involving the company and its subsidiaries. It details the amounts involved, the status of the cases, and the potential impact on profits. The document references regulatory disclosure requirements from the Shenzhen Stock Exchange but does not contain financial statements or detailed financial data. It is a regulatory announcement about legal proceedings rather than a full legal proceedings report or financial report. Therefore, it fits best under the category of Legal Proceedings Report (LTR). The document length is short and focused on legal matters, not a full audit or annual report.
2026-03-23 Chinese
关于全资子公司收到医疗器械变更注册（备案）文件的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about its wholly-owned subsidiary receiving a medical device registration change certificate issued by a provincial drug regulatory authority. It describes the product registration details and the impact on the company. The document is short (623 characters) and does not contain financial data, earnings, or management discussion. It is an official regulatory announcement about a product registration change, not a financial report, management change, or shareholder meeting material. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2026-02-06 Chinese
2025年年度业绩预告
Regulatory Filings Classification · 95% confidence The document is titled as a "2025 年年度业绩预告" which translates to "2025 Annual Performance Forecast." It provides estimated net profit figures for the full fiscal year 2025 and explanations for the expected changes in performance. The document explicitly states that the data is preliminary, unaudited, and that the final accurate financial data will be disclosed in the formal 2025 Annual Report. The document length is short (1163 characters), and it serves as a forecast or earnings guidance rather than an actual financial report. It is not a full Annual Report (10-K) or Interim Report (IR) because it lacks audited financial statements or substantive financial data. It is also not an Earnings Release (ER) because it is a forecast for the full year, not a quarterly or periodical earnings announcement. This type of document is best classified as a Regulatory Filing (RNS) because it is a formal announcement of performance expectations without full financial statements or audit results, and it does not fit other more specific categories.
2026-01-28 Chinese
关于全资子公司收到医疗器械变更注册（备案）文件的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (629 characters) from a company about its wholly owned subsidiary receiving a medical device registration change certificate from a regulatory authority. It describes the nature of the change and its potential impact on the company. There are no financial statements, no detailed financial data, no earnings or management discussion, and no mention of shareholder votes or meetings. The document is an official announcement of a regulatory update related to product registration, not a financial report or meeting material. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-12-29 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.